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Introduction

Wound healing is a dynamic, interactive process consisting of three major phases that overlap in time: inflammation, granulation tissue development (including re-epithelialisation) and tissue remodelling [1]. Granulation tissue development involves the generation of new connective tissue and new blood vessels within the wound during the healing process. Angiogenesis, the process of generation of new blood vessels from pre-existing vessels, functions to provide oxygen and nutrients to the injured area and is a key step in the development of the healing (granulation) tissue. The proper development of this tissue establishes the foundation for the subsequent events during the healing process, including wound contraction and generation of wound tensile strength.
Angiogenesis is necessary for normal wound healing. Indeed, when angiogenesis is decreased, the result is impaired healing [2] . [4, 5] . The work presented here shows that insulin is another stimulator of angiogenesis.
The development of new blood vessels requires the proliferation and migration of endothelial cells [3], which is initiated by a cross-talk between cells and the surrounding microenvironment. This includes signals stimulated by numerous factors, such as acidic and basic FGF, VEGF, TGF-␤ and angiogenin
The use of insulin for non-diabetic purposes began in the early part of the twentieth century [6, 7] and has been used to improve bone healing in rats [8] , incision or burn wounds of the skin [9, 10] and cutaneous ulcerations in diabetic and non-diabetic mice [11] . Insulin also appears to exert some effects on the vasculature. Previous studies have shown that insulin has vasculo-protective effects on endothelial cells by stimulating the release of NO from these cells [12, 13] . NO is a potent modulator of microvascular permeability [14] ; it inhibits oxidant-induced dysfunction of the endothelial cell barrier [15] and reduces reperfusion-induced cardiac injury [16] . Furthermore 
Preparation of tissues for histology
The animals were anesthetized, as described above, and skin samples were collected using a skin punch biopsy (7 mm 
Statistical analysis
Data are shown as mean Ϯ standard deviation (SD). Data analysis was performed using the unpaired Student's t-test on raw data with GraphPad
Instat software (GraphPad Software, Inc.).
Results
Subcutaneous injections of insulin stimulate angiogenesis in vivo.
Insulin stimulates wound healing in mouse excision wounds and rat burn wounds [10] . (Fig. 1D ).
Insulin stimulates microvascular endothelial cell migration in a time-and dose-dependent manner
We used HMEC to determine the effects of insulin on endothelial proliferation and migration, processes involved in angiogenesis. [3, 19, 20] . Indeed, following 24 and 48 hrs of insulin treatment, we detected elevated VEGF levels in the endothelial cell culture medium (Fig. 3C) . (Fig. 3D) , suggesting that insulin-induced endothelial cell migration does not require VEGFR signalling.
In order to determine whether insulin-induced endothelial cell migration is mediated by VEGF, we pre-treated the cells with SU1498, a selective inhibitor of the VEGF receptor 2 (VEGFR-2), prior to treatment with insulin or VEGF and measured migration distances at 24 and 48 hrs. This VEGFR inhibitor completely abolished VEGF-induced cell migration but did not alter insulin-induced migration
PI3K and Akt mediate insulin-induced microvascular endothelial cell migration and tube formation
The activation of PI3K-Akt is important for growth factor-induced cell proliferation, migration and survival. Therefore, we investigated whether insulin promotes the phosphorylation/activation of Akt and found that the levels of phosphorylated Akt increased after 3 min. of insulin treatment and remained elevated for at least 60 min. (Fig. 4A) . This effect was dose-dependent, with the higher insulin concentrations stimulating stronger Akt phosphorylation (Fig. 4B) . Akt is phosphorylated and activated downstream of PI3K [21] ; indeed, inhibition of PI3K with LY294002 prevented insulininduced Akt phosphorylation (Fig. 4C) . We also used this inhibitor to determine the importance of PI3K-Akt activity in insulininduced cell migration and tube formation and found that inhibition of the PI3K-Akt pathway abolished both insulin-mediated processes ( Fig. 4D and E) . These results show that insulin stimulation of endothelial cell migration and tube formation is dependent upon PI3K and Akt.
SREBP-1 is involved in insulin-induced microvascular endothelial cell migration and angiogenesis
SREBPs are key transcription factors that regulate cholesterol and fatty acid biosynthesis pathways and are thus important in membrane lipid biosynthesis [22] (Fig. 6A-E) , and a decreased number of blood vessels staining with ␣-SMA (Fig. 6F) [23, 24] , which regulates the biosynthesis of farnesyl pyrophosphate Fig 2. (Fig. 7D) . (Fig. 8A) . Similarly, insulin-induced tube formation was observed in nontransfected cells (Fig. 8B and C) and in cells transfected with Rac1-CA ( Fig. 8D and E) or Rac1-WT (Fig. 8H and I) but not in cells transfected with Rac1-DN (Fig. 8F and G [28, 29] . Indeed, following new microvessel development, the nascent vessels must undergo a maturation process, both within the vascular network and within the vessel wall, in order to function properly. Maturation of the vascular network involves vascular branching, expansion and pruning [31] , whereas maturation of the vascular wall involves the recruitment of mural cells, such as pericytes and smooth muscle cells that express ␣-SMA [32] . These cells are important support structures for the blood vessels [33] [34] [35] [36] [37] [38] , important components of the plasma membrane. Increasing evidence suggests that SREBPs are the primary regulators of HMGR [39, 24] . This enzyme regulates the biosynthesis of FPP and GGPP [40] , two components of isoprenoids. Isoprenoids mediate the function of the RhoA family of GTPases to which Rac1 belongs. These GTPases are geranylgeranylated proteins, and inhibition of HMGR blocks the translocation or redistribution of Rho family of proteins from the cytoplasm to the membrane [41] . Also, Rac1 is known to regulate actin assembly [42] and stimulate formation of lamellipodia [43] [44] , differentiation [45] and survival [46] 
precursor and the cleaved/mature forms of SREBP-1 showed an increase in the mature form within 3 min. of insulin treatment (Fig. 5A). To determine the involvement of SREBP-1 in insulininduced endothelial cell migration, we pre-treated these cells with an SREBP inhibitor, 25-HC, and found that this inhibitor blocks cell migration (Fig. 5B). In addition, the PI3K inhibitor LY294002 inhibits SREBP-1 activation (Fig. 5C), suggesting that insulin-stimulated SREBP-1 activation is mediated by PI3K-Akt, and that this activation is important in insulin-induced cell migration. To determine whether the PI3k-Akt-SREBP signalling pathway activated by insulin in cultured endothelial cells is involved in insulin-induced angiogenesis in vivo, we injected 25-HC to inhibit SREBP prior to insulin treatment. This pre-treatment inhibited insulin-induced angiogenesis, as shown by the decrease in the area of CD31-positive cells
. These data, taken together, show that the PI3k-Akt-SREBP signalling pathway is involved in insulin-induced angiogenesis in vivo.
Insulin stimulates Rac1 membrane translocation and this effect occurs downstream of the PI3K-Akt-SREBP-1 pathway
SREBPs are the major regulators of HMG CoA reductase (HMGR)
Fig. 3 Insulin stimulates microvascular endothelial cell migration in an insulin receptor-dependent and a VEGF-independent manner. Endothelial cells were plated for the cloning ring migration assay, as described in
To determine whether the Rac1 activation is essential in insulin-induced endothelial cell migration, the cells were transfected with plasmids containing mutant forms of Rac1, the constitutively active form of Rac1 (V12, Rac1-CA), dominant-negative mutant Rac1 (N17, Rac1-DN) or wild type Rac1 (Rac1-WT). Twenty-four hours after transfection, the cells were seeded for cloning ring migration assays and plated on Matrigel for tube formation assays. Cell migration distances were measured in nontransfected and transfected cells at 24 and 48 hrs after insulin treatment. Insulin-induced migration was observed in non-transfected cells as well as in cells transfected with Rac1-CA or Rac1-WT but was prevented in cells transfected with Rac1-DN
Fig. 4 PI3K-Akt mediates insulin-induced microvascular endothelial cell migration and tube formation: (A) Endothelial cells were treated with
